Gagliardini, Roberta
 Distribuzione geografica
Continente #
NA - Nord America 1.107
EU - Europa 991
AS - Asia 606
SA - Sud America 121
AF - Africa 16
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.844
Nazione #
US - Stati Uniti d'America 1.074
SG - Singapore 291
DE - Germania 216
PL - Polonia 198
FR - Francia 158
SE - Svezia 143
CN - Cina 136
IT - Italia 104
BR - Brasile 99
VN - Vietnam 52
UA - Ucraina 43
GB - Regno Unito 39
IN - India 35
IE - Irlanda 30
ID - Indonesia 18
CA - Canada 16
FI - Finlandia 16
RU - Federazione Russa 15
HK - Hong Kong 13
BD - Bangladesh 12
AR - Argentina 11
JP - Giappone 11
TR - Turchia 11
MX - Messico 9
NL - Olanda 7
IR - Iran 5
JM - Giamaica 5
BE - Belgio 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
LT - Lituania 3
MA - Marocco 3
TN - Tunisia 3
AT - Austria 2
AU - Australia 2
CL - Cile 2
DK - Danimarca 2
EC - Ecuador 2
EG - Egitto 2
ES - Italia 2
IQ - Iraq 2
KE - Kenya 2
MD - Moldavia 2
PA - Panama 2
PH - Filippine 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
CO - Colombia 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MM - Myanmar 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.844
Città #
Kraków 188
Chandler 173
Singapore 148
San Jose 80
Ashburn 78
New York 60
Jacksonville 47
Dublin 30
Redmond 30
Beijing 28
Los Angeles 27
Milan 27
The Dalles 26
San Mateo 25
Houston 24
Ho Chi Minh City 19
Ann Arbor 18
Dallas 18
Jakarta 18
Lauterbourg 18
Nanjing 18
Dearborn 17
Boston 16
Nürnberg 14
Wilmington 14
Cattolica 13
Hanoi 13
Hong Kong 12
Frankfurt am Main 11
Lawrence 11
Rome 11
Lancaster 10
Changsha 9
Nanchang 9
Santa Clara 9
Tokyo 9
Woodbridge 9
Fairfield 8
Roubaix 8
Buffalo 7
Izmir 7
Montreal 7
Redwood City 7
Seattle 7
São Paulo 7
Warsaw 7
Atlanta 6
Munich 6
Paris 6
Princeton 6
Pune 6
Kunming 5
Marseille 5
Toronto 5
Verona 5
Washington 5
Amsterdam 4
Augusta 4
Bexley 4
Brooklyn 4
Brussels 4
Chennai 4
Falls Church 4
Hangzhou 4
Hebei 4
Manchester 4
Mexico City 4
Orem 4
Shenyang 4
Stockholm 4
Anápolis 3
Biên Hòa 3
Boardman 3
Cambridge 3
Des Moines 3
Guangzhou 3
Helsinki 3
Jinan 3
Johannesburg 3
Kingston 3
Leawood 3
Little Rock 3
Phoenix 3
Portsmouth 3
Queens 3
San Francisco 3
Turin 3
University Park 3
Andover 2
Ankara 2
Araçatuba 2
Bari 2
Brasília 2
Bremen 2
Calgary 2
Chicago 2
Clearwater 2
Council Bluffs 2
Cupertino 2
Córdoba 2
Totale 1.541
Nome #
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 230
Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk 219
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 219
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 217
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 209
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 197
Safety and therapeutic efficacy of the switch to maraviroc+darunavir/ritonavir in HIV/HCV coinfected patients: initial results from GUSTA study 191
Ophthalmic artery resistance index IS increased in HIV-Infected patients and is influenced by protease inhibitors exposure 188
Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients 169
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 157
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 151
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 144
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 139
Liver fibrosis progression and clinical outcomes are intertwined: Role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCVcoinfected patients with detectable HCV-RNA A MASTER cohort study 134
Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study 117
3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir 110
Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors 84
Totale 2.875
Categoria #
all - tutte 10.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.474


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/2022193 4 10 4 17 6 14 4 33 12 28 26 35
2022/2023401 64 65 26 64 27 52 7 47 40 1 7 1
2023/2024200 6 62 4 22 12 48 14 1 0 2 21 8
2024/2025344 3 13 20 11 38 6 8 28 69 23 68 57
2025/2026803 123 10 39 106 166 33 150 38 35 58 33 12
Totale 2.875